FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079344641> ?p ?o ?g. }

• W2079344641 endingPage "2100" @default.
• W2079344641 startingPage "2093" @default.
• W2079344641 abstract "Thiazolidinediones have shown antidepressant effect in animal studies, as well as in some uncontrolled studies evaluating human subjects with concurrent major depressive disorder (MDD) and metabolic syndrome. Although these drugs are insulin sensitizers, they also have important anti-inflammatory, neuroprotective, and anti-excitotoxic properties. Thus, we hypothesized that they would show antidepressant effect in patients with MDD even if it was not accompanied by metabolic disturbances. In this double-blind placebo-controlled study, 40 patients with MDD (DSM-IV-TR) and Hamilton depression rating scale-17 (Ham-D) score ≥ 22 were randomized to citalopram plus pioglitazone (15 mg every 12 h) (n=20) or citalopram plus placebo (n=20) for 6 weeks. Patients were evaluated using Ham-D (weeks 0, 2, 4, 6). Repeated-measure analysis of variance (ANOVA) and analysis of covariance were used for comparison of scores between the two groups. Treatment response (≥ 50% reduction in Ham-D score), remission (Ham-D score ≤ 7), and early improvement (≥ 20% reduction in Ham-D score within the first 2 weeks) were compared between the two groups using Fisher's exact test. Pioglitazone showed superiority over placebo during the course of the trial (F(1, 38)=9.483, p=0.004). Patients in the pioglitazone group had significantly lower scores at all time points than the placebo group (P<0.01). Frequency of early improvement, response (week 6), and remission was significantly higher in the pioglitazone group (95%, 95%, 45%, respectively) than in the placebo (30%, 40%, 15% respectively) group (P<0.001, <0.001, 0.04, respectively). Frequency of side effects was similar between the two groups. Pioglitazone is a safe and effective adjunctive short-term treatment in patients with moderate-to-severe MDD even in the absence of metabolic syndrome and diabetes." @default.
• W2079344641 created "2016-06-24" @default.
• W2079344641 creator A5005104795 @default.
• W2079344641 creator A5030197592 @default.
• W2079344641 creator A5040341334 @default.
• W2079344641 creator A5086081736 @default.
• W2079344641 creator A5088810181 @default.
• W2079344641 date "2012-05-02" @default.
• W2079344641 modified "2023-10-15" @default.
• W2079344641 title "Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial" @default.
• W2079344641 cites W1965820739 @default.
• W2079344641 cites W1970456212 @default.
• W2079344641 cites W1976582031 @default.
• W2079344641 cites W1982311681 @default.
• W2079344641 cites W1983437604 @default.
• W2079344641 cites W1987446423 @default.
• W2079344641 cites W1991991343 @default.
• W2079344641 cites W1997146656 @default.
• W2079344641 cites W1999999989 @default.
• W2079344641 cites W2007880575 @default.
• W2079344641 cites W2026259136 @default.
• W2079344641 cites W2028931949 @default.
• W2079344641 cites W2033020443 @default.
• W2079344641 cites W2033138490 @default.
• W2079344641 cites W2034822289 @default.
• W2079344641 cites W2035361482 @default.
• W2079344641 cites W2038119785 @default.
• W2079344641 cites W2049808835 @default.
• W2079344641 cites W2052094743 @default.
• W2079344641 cites W2054685711 @default.
• W2079344641 cites W2057091987 @default.
• W2079344641 cites W2061114936 @default.
• W2079344641 cites W2067694641 @default.
• W2079344641 cites W2082823754 @default.
• W2079344641 cites W2085758661 @default.
• W2079344641 cites W2091516275 @default.
• W2079344641 cites W2102656145 @default.
• W2079344641 cites W2117563681 @default.
• W2079344641 cites W2119660434 @default.
• W2079344641 cites W2121789874 @default.
• W2079344641 cites W2123290069 @default.
• W2079344641 cites W2125344994 @default.
• W2079344641 cites W2126693467 @default.
• W2079344641 cites W2132303235 @default.
• W2079344641 cites W2138681004 @default.
• W2079344641 cites W2149402043 @default.
• W2079344641 cites W2151590183 @default.
• W2079344641 cites W2152596342 @default.
• W2079344641 cites W2160313172 @default.
• W2079344641 cites W2172062051 @default.
• W2079344641 cites W2178666919 @default.
• W2079344641 cites W2412677285 @default.
• W2079344641 doi "https://doi.org/10.1038/npp.2012.58" @default.
• W2079344641 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3398722" @default.
• W2079344641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22549115" @default.
• W2079344641 hasPublicationYear "2012" @default.
• W2079344641 type Work @default.
• W2079344641 sameAs 2079344641 @default.
• W2079344641 citedByCount "117" @default.
• W2079344641 countsByYear W20793446412012 @default.
• W2079344641 countsByYear W20793446412013 @default.
• W2079344641 countsByYear W20793446412014 @default.
• W2079344641 countsByYear W20793446412015 @default.
• W2079344641 countsByYear W20793446412016 @default.
• W2079344641 countsByYear W20793446412017 @default.
• W2079344641 countsByYear W20793446412018 @default.
• W2079344641 countsByYear W20793446412019 @default.
• W2079344641 countsByYear W20793446412020 @default.
• W2079344641 countsByYear W20793446412021 @default.
• W2079344641 countsByYear W20793446412022 @default.
• W2079344641 countsByYear W20793446412023 @default.
• W2079344641 crossrefType "journal-article" @default.
• W2079344641 hasAuthorship W2079344641A5005104795 @default.
• W2079344641 hasAuthorship W2079344641A5030197592 @default.
• W2079344641 hasAuthorship W2079344641A5040341334 @default.
• W2079344641 hasAuthorship W2079344641A5086081736 @default.
• W2079344641 hasAuthorship W2079344641A5088810181 @default.
• W2079344641 hasBestOaLocation W20793446411 @default.
• W2079344641 hasConcept C102959455 @default.
• W2079344641 hasConcept C105795698 @default.
• W2079344641 hasConcept C126322002 @default.
• W2079344641 hasConcept C134018914 @default.
• W2079344641 hasConcept C142724271 @default.
• W2079344641 hasConcept C204787440 @default.
• W2079344641 hasConcept C27081682 @default.
• W2079344641 hasConcept C2777180221 @default.
• W2079344641 hasConcept C2777490545 @default.
• W2079344641 hasConcept C2778384471 @default.
• W2079344641 hasConcept C2779144063 @default.
• W2079344641 hasConcept C2779177272 @default.
• W2079344641 hasConcept C2780051608 @default.
• W2079344641 hasConcept C2781161787 @default.
• W2079344641 hasConcept C33923547 @default.
• W2079344641 hasConcept C555293320 @default.
• W2079344641 hasConcept C71924100 @default.
• W2079344641 hasConcept C99476002 @default.
• W2079344641 hasConceptScore W2079344641C102959455 @default.
• W2079344641 hasConceptScore W2079344641C105795698 @default.

• next